Table 2.
HR | 95% CI | P value | |
---|---|---|---|
Model One† | |||
LDL-C ≥ 3.0 mmol/L vs. <3.0 mmol/L | 1.41 | 1.13 to1.75 | .0024 |
HDL-C, mmol/L | 0.61 | 0.45 to 0.84 | .0080 |
Triglyceride, mmol/L | 1.08 | 0.97 to 1.21 | .1669 |
Model Two‡ | |||
LDL-C ≥ 3.0 mmol/L vs. <3.0 mmol/L | 1.36 | 1.08 to 1.71 | .0095 |
HDL-C, mmol/L | 0.59 | 0.42 to 0.82 | .0020 |
Triglyceride, mmol/L | 1.02 | 0.88 to 1.17 | .9614 |
†, Not adjusted for other covariates;
‡, Adjusted for age, smoking status, duration of diabetes, HbA1c, Ln (ACR + 1), use of statins, fibrates, gliclazide and rosiglitazone during follow-up, years of enrolment (selected by the stepwise algorithm with P = .10 for entry and stay).